A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients
In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.
Foundation Researcher Studies Role of IL-17 in Rheumatoid Arthritis
A grant from the American College of Rheumatology (ACR)’s Rheumatology Research Foundation has helped Shiva Shahrara, PhD, conduct research into the molecule, IL-17, that plays a role in recruiting myeloid cells to migrate from the blood to the joint and perpetuating vascularization
What’s in Store for Rheumatology in the 113th Congress?
In addition to seeking improvements to the Affordable Care Act, the American College of Rheumatology (ACR) will promote other legislative healthcare priorities including physician payment reform, patient access to treatment, and funding for medical research
A Spotlight on IgG4-Related Disease
What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)
ACR/ARHP Annual Meeting 2012: Identify Compliance Risks to Avoid Violating Medicare Rules
Rheumatologists should develop a plan to keep in step with federal regulations
ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?
Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit
What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)
Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
Strategic Thinking to Advance Rheumatology in the New Year
One of the first efforts this coming year will be the development of the American College of Rheumatology’s (ACR’s) 2013-2016 strategic plan
No Easy Solution for Lack of Transparency in the Practice of Medicine
Several well-publicized episodes highlight the apparent lack of disclosure of conflicts of interest in medicine, but will disclosure laws fix the problem or add to the confusion?
- « Previous Page
- 1
- …
- 194
- 195
- 196
- 197
- 198
- …
- 248
- Next Page »